Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Nicotine-induced endothelial dysfunction is prevented by captopril
October 25th, 2006
Research from the People's Republic of China reports that captopril protects from nicotine-induced endothelial dysfunction. "This study was designed to examine the in vivo and in vitro effects of captopril, an angiotensin-converting enzyme inhibitor, on nicotine-induced endothelial dysfunction in rats," wrote H.L. Luo and colleagues of Xian Jiaotong University. "Endothelial dysfunction was induced by exposing isolated rat mesenteric arteries to nicotine (0.01, 0.1, or 1 mM) for 24 hr using an organ culture system, or by treating rats with nicotine (2 mg/kg/day, intraperitoneally) for 4 weeks," they explained. "The protective effects of captopril were...
Source: Biotech Week (2006-10-25)
|
